From Promise to Proof: Personalized Melanoma mRNA Vaccine Delivers Phase III Success
Results from a phase III trial showed that a cancer vaccine can improve outcomes for certain patients with melanoma,...
Tag: Melanoma
Results from a phase III trial showed that a cancer vaccine can improve outcomes for certain patients with melanoma,...
The June edition of Editors’ Picks from the AACR journals included studies on targeting neural cross-talk to stop glioblastoma...
Melanoma expert Ashani T. Weeraratna, PhD, of Johns Hopkins Bloomberg School of Public Health, explains how bemotrizinol—the first new...
The latest edition of our "From the Bench" series examines creative research approaches presented at the AACR Annual Meeting...
This year, Party with a Purpose honors melanoma researchers Lynn Schuchter and Alexander Huang, and humanitarian honoree Patricia Wellenbach.
This month, the AACR's journals editors highlighted studies on U.S. cancer mortality hotspots, chemotherapy-induced hearing loss, and more.
The journey to the first approved TIL therapy began with Steven A. Rosenberg over 30 years ago.
It sounds like something out of Frankenstein, but a new study in the AACR journal Cancer Discovery suggests that...
Our five senses provide us with the crucial information we need to interact with the world. On a physiological...
Melanoma is an aggressive form of skin cancer. While it is less common than skin cancers like basal cell...